关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Guangxi Province is implementing drug

Release time:

2023-07-24

Product Name Specifications Packaging
Ambroxol Hydrochloride Capsules 30mg 30mg×24 capsules/box
Cefoxitin Sodium for Injection 0.5g Based on C16H17N307S2 calculation 0.5g×1 bottle/box
Ambroxol Hydrochloride Capsules 60mg 60mg×12 capsules/box
Azithromycin for Injection 0.5g 0.5g×10 sticks/box
Diammonium glycyrrhizinate enteric-coated tablets 50mg 50mg×24 tablets/box
Anetellithin Tablets 25mg 25mg×12 tablets/box
Sodium fructose diphosphate for injection 5g (as anhydrous) 5g (according to anhydrous matter)×1 bottle/bottle
Sodium ferulate for injection 0.1g 0.1g×1 bottle/box
Fenofibrate Capsules 0.2g 0.2g×20 tablets/box
Guipi Capsule 0.3g per capsule Each capsule contains 0.3g×24 capsules/box
Guipi Capsule 0.3g 0.3g×36 capsules/box
Clindamycin Phosphate Injection 2ml:0.3g 2ml:0.3g×10 bottles/box
Clindamycin Phosphate Injection 4ml:0.6g 4ml:0.6g×10 bottles/box
Lysine for Injection 0.9g 0.9g×1 bottle/bottle
Fenofibrate Capsules 0.2g 0.2g×10 tablets/box
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs